Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
137
datasets available to search
ShareScore release 0.9.0
Dataset results
137 results for “treatment duration”
Comparison of Duration of Treatment Interruption With or Without Curcumin During the Off Treatment Periods in Patients With Prostate Cancer Undergoing Intermittent Androgen Deprivation Therapy
ClinicalTrials.gov study NCT03211104. IPD Sharing: Not stated. Countries: 0. Publications: 2.
A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment
ClinicalTrials.gov study NCT01468077. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)
ClinicalTrials.gov study NCT00171301. IPD Sharing: Not stated. Countries: 5. Publications: 0.
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)
ClinicalTrials.gov study NCT03897036. IPD Sharing: NO. Countries: 1. Publications: 0.
Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
ClinicalTrials.gov study NCT00535418. IPD Sharing: Not stated. Countries: 0. Publications: 1.
High-Power, Short-Duration Ablation in Treatment of Patients With Atrial Fibrillation
ClinicalTrials.gov study NCT06415149. IPD Sharing: YES. Countries: 1. Publications: 0.
Duration of Antibiotic Treatment for Early VAP (DATE) Trial
ClinicalTrials.gov study NCT01994980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD
ClinicalTrials.gov study NCT06577779. IPD Sharing: NO. Countries: 1. Publications: 0.
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
ClinicalTrials.gov study NCT01187381. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Relationship Between Duration of Treatment and Response in Patients With Multiple Myeloma (MM) or Systemic AL Amyloidosis Treated in Real-life Practice
ClinicalTrials.gov study NCT04659798. IPD Sharing: YES. Countries: 1. Publications: 0.
Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic Migraine
ClinicalTrials.gov study NCT02037425. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in
ClinicalTrials.gov study NCT05819112. IPD Sharing: YES. Countries: 1. Publications: 0.
Data from: The fracture failure of granite after varied durations of thermal treatment: an experimental study
Open the record for dataset details and reuse information.
RNA Sequencing with de novo assembly of earthworm transcriptome by the treatment of lindane with different exposure and aging duration.
GEO Series GSE118678. Eisenia fetida. 15 samples. Type: Expression profiling by high throughput sequencing.
Data from: Durations and delays in care seeking, diagnosis and treatment initiation in uncomplicated pulmonary tuberculosis patients in Mumbai, India
Background: Timely diagnosis and treatment initiation are critical to reduce the chain of transmission of Tuberculosis (TB) in places like Mumbai, where almost 60% of the inhabitants reside in overcrowded slums. This study documents the pathway from the onset of symptoms suggestive of TB to initiation of TB treatment and examines factors responsible for delay among uncomplicated pulmonary TB patients in Mumbai. Methods: A population-based retrospective survey was conducted in the slums of 15 high TB burden administrative wards to identify 153 self-reported TB patients. Subsequently in-depth interviews of 76 consenting patients that fit the inclusion criteria were undertaken using an open-ended interview schedule. Mean total, first care seeking, diagnosis and treatment initiation duration and delays were computed for new and retreatment patients. Patients showing defined delays were divided into outliers and non-outliers for all three delays using the median values. Results: The mean duration for the total pathway was 65 days with 29% of patients being outliers. Importantly the mean duration of first care seeking was similar in new (24 days) and retreatment patients (25 days). Diagnostic duration contributed to 55% of the total pathway largely in new patients. Treatment initiation was noted to be the least among the three durations with mean duration in retreatment patients twice that of new patients. Significantly more female patients experienced diagnostic delay. Major shift of patients from the private to public sector and non-allopaths to allopaths was observed, particularly for treatment initiation. Conclusion: Achieving positive behavioural changes in providers (especially non-allopaths) and patients needs to be considered in TB control strategies. Specific attention is required in counselling of TB patients so that timely care seeking is effected at the time of relapse. Prioritizing improvement of environmental health in vulnerable locations and provision of point of care diagnostics would be singularly effective in curbing pathway delays.
Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence
ClinicalTrials.gov study NCT01038414. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer
ClinicalTrials.gov study NCT06613165. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Single-armed Investigation to Evaluate the Safety of pHyph Following a Prolonged Treatment Duration in Adult Women With Bacterial Vaginosis
ClinicalTrials.gov study NCT07394777. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Response in Chronic Hepatitis C (CHC) Participants Genotype 1 With Insulin Resistance and Prolonged Treatment Duration in Late Responders (P04823/MK-4031-303)
ClinicalTrials.gov study NCT00493805. IPD Sharing: YES. Countries: 0. Publications: 0.
EXtension of Tablo TrEatmeNt Duration Registry
ClinicalTrials.gov study NCT04912050. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.